169 related articles for article (PubMed ID: 19549334)
1. Akt finds its new path to regulate cell cycle through modulating Skp2 activity and its destruction by APC/Cdh1.
Gao D; Inuzuka H; Tseng A; Wei W
Cell Div; 2009 Jun; 4():11. PubMed ID: 19549334
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.
Gao D; Inuzuka H; Tseng A; Chin RY; Toker A; Wei W
Nat Cell Biol; 2009 Apr; 11(4):397-408. PubMed ID: 19270695
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APC(Cdh1) in G1 phase.
Rodier G; Coulombe P; Tanguay PL; Boutonnet C; Meloche S
EMBO J; 2008 Feb; 27(4):679-91. PubMed ID: 18239684
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2.
Boutonnet C; Tanguay PL; Julien C; Rodier G; Coulombe P; Meloche S
Cell Cycle; 2010 Mar; 9(5):975-9. PubMed ID: 20160482
[TBL] [Abstract][Full Text] [Related]
5. Dissection of the APCCdh1-Skp2 cascade in breast cancer.
Fujita T; Liu W; Doihara H; Date H; Wan Y
Clin Cancer Res; 2008 Apr; 14(7):1966-75. PubMed ID: 18381934
[TBL] [Abstract][Full Text] [Related]
6. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.
Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI
Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Skp2-p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis.
Fujita T; Liu W; Doihara H; Wan Y
Am J Pathol; 2008 Jul; 173(1):217-28. PubMed ID: 18535175
[TBL] [Abstract][Full Text] [Related]
8. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
[TBL] [Abstract][Full Text] [Related]
9. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
10. SCF
Li F; Mladenov E; Mortoga S; Iliakis G
Cell Death Dis; 2020 Jul; 11(7):548. PubMed ID: 32683422
[TBL] [Abstract][Full Text] [Related]
11. Acetylation-dependent regulation of Skp2 function.
Inuzuka H; Gao D; Finley LW; Yang W; Wan L; Fukushima H; Chin YR; Zhai B; Shaik S; Lau AW; Wang Z; Gygi SP; Nakayama K; Teruya-Feldstein J; Toker A; Haigis MC; Pandolfi PP; Wei W
Cell; 2012 Jul; 150(1):179-93. PubMed ID: 22770219
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation.
Cuende J; Moreno S; Bolaños JP; Almeida A
Oncogene; 2008 May; 27(23):3339-44. PubMed ID: 18212744
[TBL] [Abstract][Full Text] [Related]
13. Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition.
Liu W; Wu G; Li W; Lobur D; Wan Y
Mol Cell Biol; 2007 Apr; 27(8):2967-79. PubMed ID: 17283060
[TBL] [Abstract][Full Text] [Related]
14. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex.
Wei W; Ayad NG; Wan Y; Zhang GJ; Kirschner MW; Kaelin WG
Nature; 2004 Mar; 428(6979):194-8. PubMed ID: 15014503
[TBL] [Abstract][Full Text] [Related]
15. The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.
Shapira M; Kakiashvili E; Rosenberg T; Hershko DD
Breast Cancer Res; 2006; 8(4):R46. PubMed ID: 16859513
[TBL] [Abstract][Full Text] [Related]
16. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) by Akt promotes stability and mitogenic function of S-phase kinase-associated protein-2 (Skp2).
Song GJ; Leslie KL; Barrick S; Mamonova T; Fitzpatrick JM; Drombosky KW; Peyser N; Wang B; Pellegrini M; Bauer PM; Friedman PA; Mierke DF; Bisello A
J Biol Chem; 2015 Jan; 290(5):2879-87. PubMed ID: 25492869
[TBL] [Abstract][Full Text] [Related]
18. An in vivo study of Cdh1/APC in breast cancer formation.
Fujita T; Liu W; Doihara H; Wan Y
Int J Cancer; 2009 Aug; 125(4):826-36. PubMed ID: 19350629
[TBL] [Abstract][Full Text] [Related]
19. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
20. The dual effects of Cdh1/APC in myogenesis.
Li W; Wu G; Wan Y
FASEB J; 2007 Nov; 21(13):3606-17. PubMed ID: 17601983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
